Not Tagged
nrg oncology
[]
. s dr. patrick boland ( ) &amp; colleagues present phase ii/iii study of circulating tumor dna as a predictive biomarker in adjuvant chemotherapy in patients with stage ii #colon cancer: nrg-gi005 (cobra) #gi23 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.